Model-Predictive Design, Control, and Optimization - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Model-Predictive Design, Control, and Optimization
Applying model-predictive methods and a continuous process-control framework to a continuous tablet-manufacturing process. This article contains bonus online-exclusive material.


Pharmaceutical Technology
Volume 37, Issue 6, pp. 40-41, 77

References

1. T. Garcia, G. Cook, R. Nosal, J. Pharm Innovation, 3 (2), 60-68 (2008).

2. R. Lionberger, et al., The AAPS Journal, 10(2), 268-276 (2008).

3. R. Nosal, T. Schultz, J. Pharm Innovation, 3(2), 69-78 (2008).

4. L. Yu, Pharm. Research, 25(4), 781-791 (2008).

5. J. Lepore and J. Spavins, J. Pharm. Innovation 3 (2) 79-87 (2008).

6. F. Boukouvala, Y. Gao, F. Muzzio, and M.G. Ierapetritou, Chem. Eng. Sci. 95, 12-26 (2013).

7. T. Hőrmann, D. Suzzi, S. Adam, and J.G. Khinast, J. Pharm. Innovation 7 (3-4), 181-194 (2012).

8. F. Boukouvala, F. Muzzio, and M.G. Ierapetritou, AIChE J. 56 (11), 2860-2872 (2010).

9. A. Chaudhury, A. Niziolek, and R. Ramachandran, Adv. Pow. Tech. 24 (1) 113-131 (2013).

10. E. S. Szalai, P. Arratia, K. Johnson, and F. J. Muzzio, Chem. Eng. Sci. 59, 3793-3805 (2004).

11. D.R. Unger, F.J. Muzzio, J.G. Aunins, and R. Singhvi, R., Biotech. and Bioeng. 70, 117-130, (2000).

12. P.D. Swanson, F.J. Muzzio, A. Annapragada, and A. Adjei, Intl. J. Pharmaceutics 142, 33-51 (1996).

13. M. Moakher, T. Shinbrot, and F.J. Muzzio, Pow. Tech. 109, 58-71 (2000).

14. F. Boukouvala, et al., Computers & Chem. Eng., 42, 30-47 (2012).

15. R. Singh, et al., PharmPro Mag. 27 (6), 22-25 (2012).

16. F. Boukouvala, et al., J. Pharm. Innovation 8 (1) 11-27 (2013).

17. R. Singh, M. G. Ierapetritou, and R. Ramachandran, Eur. J. Pharm. and Biopharm. online, http://dx.doi.org/10.1016/j.ejpb.2013.02.019

18. R. Singh, M. G. Ierapetritou, and R. Ramachandran, Int. J. Pharm. 438 (1-2), 307-326 (2012).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here